definiens: shall be defined as a product that, as compared to existing Products and as demonstrated inindependent, peer - reviewed publication(s ): ( i ) offers significant technological advancements ; ( ii ) willsignificantly improve clinical outcomes or patient care ; or ( iii ) will significantly streamline workprocesses . Vendor shall provide Participants with an opportunity to purchase, at price pointscomparable to those applicable to Products under this Agreement, New Technology Products offeredby Vendor and not referenced in Exhibit A. Vendor shall notify HPG of any New Technology Product atleast thirty ( 30 ) days prior to such New Technology Product being made available for purchase throughcommercial / public release, but subsequent to FDA approval ( if applicable ) . Before offering any newproduct in the product category, including a New Technology Product, to Participants for purchase, Vendor shall : ( i ) complete any product documentation requested by HPG ; ( ii ) meet with HPG to providerequired product information to HPG and its clinical committees ; ( iii ) agree with HPG upon a price forsuch product ; and ( iv ) amend Exhibit A to add such product at the agreed upon price . If Vendor offersany new product, including a New Technology Product, to Participants for purchase prior to completing(i ) - ( iv ) above, Vendor agrees that Participants will pay the price specified on Exhibit A for the mostcomparable Product on this Agreement . HPG shall offer Vendor equal consideration and review forpotential supply commitments for New Technology Products . If HPG enters into any national or groupagreement for Participants to purchase a New Technology Product from a supplier other than Vendor, neither such agreement nor the purchase of the New Technology Product ( by itself ) shall constitute abreach of this Agreement or failure by HPG or Purchasers to meet the purchasing requirements underthis Agreement or any agreement hereunder between Vendor and a Purchaser